Shunsuke Yamazaki
Kamakura Women's University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shunsuke Yamazaki.
Laboratory Animals | 2010
Toshio Honjo; Takashi Kuribayashi; Mariko Matsumoto; Shunsuke Yamazaki; Shizuo Yamamoto
The kinetics of α 2-macroglobulin (α2M) and α 1-acid glycoprotein (AAG) in rats repeatedly stimulated with intramuscular injections of turpentine oil at doses 0.05 and 0.4 mL/rat were investigated. Mean serum levels of α2M peaked at 48 h after the first turpentine oil injection, reaching 1.74 and 2.36 mg/mL at 0.05 and 0.4 mL/rat, respectively. AAG peaks were also observed at 48 h after injection, and the mean values were 2.02 and 2.53 mg/mL, respectively. These peak values of α2M and AAG differed significantly between the 0.05 and 0.4 mL/rat injection groups. Mean serum levels of interleukin-6 (IL-6) at 0.05 mL/rat were 52.61 pg/mL at 12 h, 48.86 pg/mL at 36 h and 81.93 pg/mL at 84 h after the first injection. Mean IL-6 serum levels at 0.4 mL/rat were 215.24 pg/mL at 12 h, 56.33 pg/mL at 36 h and 39.25 pg/mL at 84 h after the first injection. Mean serum levels of cytokine-induced chemoattractant-1 (CINC-1) at a dose of 0.05 mL/rat were 5.70 ng/mL at 12 h, 5.58 ng/mL at 36 h and 4.58 ng/mL at 84 h after the first injection. Mean serum levels of CINC-1 after injection at 0.4 mL/rat were 11.57 ng/mL at 12 h, 4.68 ng/mL at 36 h and 4.42 ng/mL at 84 h. Serum levels of IL-6 differed significantly at 12, 24, 72 and 84 h, while those of CINC-1 differed significantly at 12, 24, 48 and 96 h between the 0.05 and 0.4 mL/rat injection groups. Differences in peak serum levels in the 0.05 and 0.4 mL/rat groups were attributed to differences in the production of IL-6 and CINC-1, which are thought to contribute to α2M and AAG production.
Journal of Applied Toxicology | 2004
Masahiro Takeyoshi; Shuji Noda; Shunsuke Yamazaki; Hiroshi Kakishima; Kanji Yamasaki; Ian Kimber
Archive | 2009
Tomohiro Yokota; Shunsuke Yamazaki; Hiroko Nakatsugawa; Takeshi Ikemoto; Mariko Hara; Shintaro Inoue
Experimental Animals | 2010
Toshio Honjo; Takashi Kuribayashi; Tetsurou Seita; Yui Mokonuma; Ayaka Yamaga; Shunsuke Yamazaki; Shizuo Yamamoto
Inflammation | 2015
Takashi Kuribayashi; Tetsuro Seita; Eiichi Momotani; Shunsuke Yamazaki; Kohei Hagimori; Shizuo Yamamoto
Archive | 2006
Hideyo Uchiwa; Sachiyo Hirotsu; Akinori Haratake; Takeshi Ikemoto; Junichi Matsui; Shunsuke Yamazaki; Masaki Yoshida; Motoi Odawara-shi Hayase
Journal of Dermatological Science | 2003
Kazuto Hamada; Sachiyo Hirotsu; Hideyo Uchiwa; Shunsuke Yamazaki; Keiko Suzuki
Journal of Dermatological Science | 2000
Keiko Suzuki; Shunsuke Yamazaki; Yoshiki Tokura
Journal of Applied Toxicology | 2008
Masahiro Takeyoshi; Kenji Iida; Keiko Suzuki; Shunsuke Yamazaki
Archive | 2002
Rie Hikima; Takeshi Ikemoto; Masayuki Matsumoto; Keiko Suzuki; Shunsuke Yamazaki; Tomohiro Yokota; 山崎 俊介; 引間 理恵; 松本 雅之; 横田 朋宏; 池本 毅; 鈴木 恵子